|
SCRIP: World
Pharmaceutical News
November 05, 2004
Avestha Gengraine and CCBR form joint venture in osteoporosis
The Indian biotechnology and bioinformatics company,
Avestha Gengraine Technologies, has entered into a
joint venture with the Denmark-based CRO, the Centre for Clinical & Basic
Research (CCBR), and its subsidiary, Nordic Biosciences, to work on
osteoporosis and osteoarthritis. The alliance will cover the diagnosis,
treatment and prevention of osteoporosis and osteoarthritis. The partners
expect to put together a comprehensive platform to develop novel
technologies that integrate the diagnosis and treatment of osteoporosis.
Avestha Gengraine also expects to link its competences in preclinical
research with CCBR's experience in clinical research in osteoporosis to
develop nutritional bioactive ingredients and new drug leads. Both companies
plan to jointly market these products globally.
|